Loracarbef versus clarithromycin in children with acute otitis media with effusion

Clinical Therapeutics

Volumn 21, Issue 4, 1999, Pages 711-722

  Manford Gooch III, W ^a   Adelglass, Jeffrey ^b   Kelsey, Douglas K ^c   Masica, Daniel ^c   Johns Jr , Don ^c   Weinberg, Beth C ^c  

^a Utah Medical Association   (United States)

^b Research Across America   (United States)

^c ELI LILLY AND COMPANY   (United States)

Author keywords

Clarithromycin; Loracarbef; Otitis media; Patient acceptance

Indexed keywords

CLARITHROMYCIN; LORACARBEF;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG OVERDOSE; DRUG TOLERABILITY; EAR DISEASE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT SATISFACTION; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SECRETORY OTITIS MEDIA; SINGLE BLIND PROCEDURE; TASTE; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

EID: 0033043651     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)88322-8     Document Type: Article

References (11)

1. Stool SE, Berg AO, Berman S, et al. Managing Otitis Media with Effusion in Young Children. Quick Reference Guide for Clinicians. AHCPR publication 94-0623. Rockville, Md: Agency for Health Care Policy and Research; 1994.
2. Eden AN, Fireman P, Stool SE. Managing acute otitis media: A fresh look at a familiar problem. Contemp Pediatr. 1996; 13:64-66.
3. Dagan R, Shvartzman P, Liss Z. Variation in acceptance of common oral antibiotic suspensions. Pediatr Infect Dis J. 1994;13: 686-690.
4. LY 163892 (loracarbef) product information. Indianapolis, Ind: Eli Lilly and Company; June 1995.
5. ®. Physicians' Desk Reference. 49th ed. Montvale, NJ: Medical Economics Data Production Company; 1995: 407-410.
6. Data on file. Indianapolis, Ind: Eli Lilly and Company; 1996.
7. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
8. Berlin JA, Laird NM, Sacks HS, Chalmers TC. A comparison of statistical methods for combining event rates from clinical trials. Stat Med. 1989;8:141-151.
9. 9. Lumpkin MM, Burlington DB. Points to Consider. Division of Anti-infective Drug Products, Office of Drug Evaluation II. 1992. Available at: http://www.fda.gov/cder/ guidance/index.htm. Accessed October 26, 1992.
10. Foshee WS. Study drug (LY163892) versus amoxicillin-clavulanate in the treatment of bacterial acute otitis media with effusion. J Pediatr. 1992;120:980-986.
11. Schatz BS, Karavokiros KT, Taeubel MA, Itokazu GS. Comparison of cefprozil, cefpodoxime, proxetil, study drug, cefixime, and ceftibuten. Ann Pharmacother. 1996; 30:258-268.